[Abstract] Semen contains amyloid fibrils that enhance HIV-1 infection (Münch et al., 2007; Kim et al., 2010; Roan et al., 2011; Arnold et al., 2012; Usmani et al., 2014; Roan et al., 2014) . Positively charged semen amyloids capture negatively charged viral particles and increase their attachment rates to the cell surface resulting in enhanced fusion and infection (Roan et al., 2009 ). Since semen is highly cytotoxic, we developed an assay that allows quantification of the infection enhancing activity of semen while minimizing its cell damaging activity. Here, we describe two protocols that allow the quantification of the infectivity enhancing activity of semen using a reporter cell line (TZM-bl cells) or peripheral blood mononuclear cells (PBMCs). 
2. Culture 18-24 h at 37 °C in a 5% CO2 humidified incubator.
3. The next day, without removing the medium, add 180 µl fresh complete medium containing 100 µg/ml gentamicin (and 10 ng/ml IL-2 for PBMCs).
Note: Gentamicin prevents the outgrowth of bacteria that may have contaminated the semen collection container.
4. Dilute HIV-1 stock in the complete medium to achieve a MOI < 1 (e.g., 0.1, 0.01, 0.001).
Note: The HIV-1 enhancing activity of semen cannot be observed at high MOIs as all target cells
have been already infected in the absence of semen. ii. Centrifuge for 5 min, 550 x g at room temperature.
iii. Discard supernatant.
iv. Add 40 µl of 1x lysis buffer.
v. Incubate for 10 min at room temperature.
vi.
Resuspend and transfer 30 µl of the lysed sample into a white 96-well luminometer plate.
vii. Add 100 µl substrate.
viii. Immediately, read luminescence as relative light units/s in a luminometer.
13. Evaluate raw data (Figures 3 and 4 ). 
Notes
The following issues need to be carefully considered:
1. Do not add DEAE-Dextran, polybrene, or other additives that are often used in TZM-bl assays to increase infection rates. Addition of separate enhancers will mask the infection enhancing activity of semen.
2. Use low MOIs that are either sub-infectious in the absence of semen or result in infection rates of less than 10%. Only then, an enhancing effect of semen on viral infection can be determined. In parallel, it is recommended to run cytotoxicity assays. [e.g., MTT assay (see Kim et al., 2010) or Luminescent Cell Viability Assay] 8. Assay does not need to be performed in flat 96-well plates, but can also be scaled into different formats.
If these points are considered, the experimental set up can be adapted and modified to allow measurement of infection of different target cells with any HIV strain and reporter virus (i.e., GFP followed by a flow cytometry readout), as well as other viruses such as HCMV and HSV (Tang et al., 2013; Torres et al., 2015) .
Infection enhancement by in vitro generated amyloid fibrils can be examined using the same protocol, except that the toxicity avoiding steps, i.e., addition of gentamicin, high volumes of medium, removal of toxic semen after 2-3 h can be omitted. 
